Brief: Pharmena Sets Effective Dose For 1-MNA Drug In PAH Indication Post Preclinical Study

Pharmena SA

20/12/2019 09:09

Dec 20 (Reuters) - Pharmena SA  PHR.WA :
    * RECEIVES RESULTS OF PRECLINICAL STUDY FOR 1-MNA DRUG
CONDUCTED
THROUGH ITS US-BASED UNIT CORTRIA CORPORATION
    * FOLLOWING TESTS EFFECTIVE DOSE OF 1-MNA IN PULMONARY
ARTERIAL
HYPERTENSION INDICATION WAS DETERMINED

Source text for Eikon:  ID:nEM637yQ2a 
Further company coverage:  PHR.WA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))